STOCK ALARM
PRO
SA
PRO
Market
Screener
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Amylyx Pharmaceuticals, Inc.
AMLX
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Per Share (TTM)
Revenue/Share
$-0.01
Net Income/Share
$-1.60
Operating CF/Share
$-1.65
Free CF/Share
$-1.66
Cash/Share
$3.69
Book Value/Share
$3.56
Tangible Book/Share
$3.56
Equity/Share
$3.56
Interest Debt/Share
$0.06
CapEx/Share
$0.00
Dividend/Share
$0.00
Valuation
Market Cap
$1.22B
Enterprise Value
$999.89M
P/E Ratio
-9.17
P/S Ratio
-1,833.29
P/OCF Ratio
-8.86
P/FCF Ratio
-7.89
P/B Ratio
4.12
P/TB Ratio
4.12
EV/Sales
-1,503.60
EV/EBITDA
-6.51
Graham Valuation
Graham Number
--
Graham Net-Net
$3.36
Profitability
Earnings Yield
-10.91%
FCF Yield
-12.67%
ROE
-68.95%
ROIC
-46.36%
Return on Tangible Assets
-41.15%
Dividend
Dividend Yield
0.00%
Payout Ratio
0.00%
Capital Allocation
CapEx/OCF
-0.05%
CapEx/Revenue
-10.83%
CapEx/Depreciation
0.12
SBC/Revenue
-4210.53%
SG&A/Revenue
0.00%
R&D/Revenue
-13825.86%
Liquidity & Solvency
Debt/Equity
0.02
Debt/Assets
0.02
Debt/Market Cap
0.00
Net Debt/EBITDA
1.43
Current Ratio
13.70
Interest Coverage
0.00x
Income Quality
1.03
Efficiency
Days Sales Outstanding
-127 days
Days Payables Outstanding
97 days
Days Inventory
0 days
Receivables Turnover
-2.87x
Payables Turnover
3.75x
Inventory Turnover
0.00x
Capital Structure
Tangible Assets
$332.00M
Working Capital
$327.59M
Invested Capital
$333.47M
Intangibles/Assets
0.00%